Zhongliu Fangzhi Yanjiu (Nov 2019)

Application of PSMA PET/CT Specific Molecular Imaging in Diagnosis of Non-prostate Cancer

  • LIU Teli,
  • LIU Chen,
  • ZHANG Yuqi,
  • DENG Yujiao,
  • ZHU Hua,
  • YANG Zhi

DOI
https://doi.org/10.3971/j.issn.1000-8578.2019.19.0356
Journal volume & issue
Vol. 46, no. 11
pp. 1022 – 1025

Abstract

Read online

Prostate specific membrane antigen(PSMA) is a glutamate carboxypeptidase Ⅱ secreted by the epithelial cells of prostate gland. PSMA is over-expressed in the cells of prostate cancer and metastases, and also positively expressed in the tumor-related neovascular endothelial cells. Therefore, more than twenty PSMA-targeted probes had been used for the diagnosis and therapy of prostate cancer. This article reviews the expression of PSMA in non-prostate cancer and the clinical application of PSMA-PET/CT specific probes in detecting non-prostate cancer, to expand the clinical application of novel PSMA-targeted PET probes in the diagnosis of tumors.

Keywords